| Trial ID: | L0860 |
| Source ID: | NCT02198495
|
| Associated Drug: |
Supplementation Of Ferric Carboxymaltose
|
| Title: |
Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients
|
| Acronym: |
COPEFER
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia of Chronic Kidney Disease
|
| Interventions: |
DRUG: Supplementation of ferric carboxymaltose|DRUG: Supplementation of iron sucrose
|
| Outcome Measures: |
Primary: Serum hemoglobin level (g/dl), 40 weeks | Secondary: Serum ferritin level (µg/l), Week 0, 10, 20, 30, 40|Serum transferrin level (mg/dl), Week 0, 10, 20, 30, 40|Serum level of transferrin saturation (TSAT) (%), Week 0, 10, 20, 30, 40|ESA consumption in I.E./week or µg/week as appropriate, Week 0, 10, 20, 30, 40
|
| Sponsor/Collaborators: |
Sponsor: Medical University of Vienna
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
143
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-09
|
| Completion Date: |
2019-05
|
| Results First Posted: |
|
| Last Update Posted: |
2020-09-11
|
| Locations: |
Medical University of Vienna, Division of Nephrology and Dialysis, Vienna, 1090, Austria|Wiener Dialysezentrum GmbH, Vienna, 1220, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT02198495
|
